Related Experiment Video
Updated: Sep 30, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Sarcoidosis
T J Giuffrida1, Francisco A Kerdel
1Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, 1400 NW 12th Avenue, Miami, FL 33136, USA.
Abstract:
Sarcoidosis is a systemic granulomatous disease of unknown cause that most commonly affects the lungs, lymph nodes, skin, eyes, spleen, bone, and glandular tissue. The diagnosis is made when characteristic histologic findings are demonstrated and other granulomatous processes are excluded. It can be an acute or chronic debilitating disease, but in patients with acute disease the process can be self-limited. Multiple therapeutic options have been described both for the cutaneous and systemic lesions of sarcoidosis. Steroids, however, remain the cornerstone of therapy.
Related Concept Videos
Rocky Mountain Spotted Fever
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Leishmaniasis
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Toxoplasmosis
Tuberculosis